The inherited human SRY allele p.Met64Val (codon 64 in the high-mobility-group DNA-binding domain; position 9 of the domain's consensus sequence, part of the hydrophobic wedge that intercalates into and bends DNA) causes complete 46,XY gonadal dysgenesis in some members of one pedigree while an adult carrier father and brother are normal males — the 'father-daughter paradox'. The variant retains near-native DNA affinity and bending but accelerates protein-DNA dissociation, and it reduces occupancy of the testis-specific Sox9 enhancers Enh13 and TESCO in a pre-Sertoli cell model to roughly half of wild type. What remains unresolved is the molecular mechanism of this attenuated enhancer occupancy (altered DNA bend angle at non-consensus sites, disrupted protein-protein interactions in the SRY-directed enhanceosome, or a conformationally destabilized 'molten' bound state that impairs enhanceosome assembly or promotes proteasomal degradation), its genome-wide extent, the protein composition of the testis-specific SRY enhanceosome, and what sets the human sex-determination threshold — genetic-background modifiers awaiting discovery, digenic regulatory or epigenetic contributions, or stochastic threshold crossing, an alternative the source itself offers. These strands remain untouched: no sequencing-based SRY cistrome has been published in a gonadal model (the sole genome-wide SRY target analysis, a 2012 promoter-array ChIP-chip study, predates the source), no SRY enhanceosome proteomics exists, and modifier genes of the SRY-dependent threshold remain unidentified.

Background

In therian mammals, male development is initiated by SRY (sex-determining region on the Y chromosome), a gene encoding a transcription factor whose conserved DNA-binding domain is the high-mobility-group (HMG) box, an L-shaped motif that binds specific DNA sites in the widened minor groove and introduces a sharp DNA bend of roughly 70-80 degrees. SRY's principal developmental target is SOX9/Sox9, a transcription factor whose activation in the embryonic bipotential gonadal ridge commits the supporting-cell lineage to Sertoli-cell fate and thereby launches the testis-differentiation gene-regulatory network. SRY and the nuclear receptor SF1 (steroidogenic factor 1, encoded by NR5A1) act synergistically on the ancient Sox9 enhancer TESCO (testis-specific enhancer of Sox9 core), and on the more recently discovered distal enhancer Enh13, a short element ~565 kb upstream of Sox9 whose deletion alone causes XY sex reversal in mouse and whose human equivalent is embedded in a region whose deletion causes 46,XY sex reversal. Assembly of a multiprotein protein-DNA complex (an 'enhanceosome') on such enhancers is presumed to underlie transcriptional activation, but the testis-specific SRY enhanceosome has never been defined biochemically.

Complete failure of testis development in a 46,XY individual (bearing the typical male complement of one X and one Y chromosome) — complete gonadal dysgenesis, clinically the Swyer syndrome, with uterus, fallopian tubes and streak gonads — is caused in 10-15% of cases by mutations in SRY, mostly de novo point mutations in the HMG box. Rare inherited SRY mutations create a puzzle: the same variant Y chromosome is transmitted by a fertile father yet produces an infertile 46,XY daughter with gonadal dysgenesis (the 'father-daughter paradox'). Known molecular explanations for such variable penetrance include partial impairment of nuclear import (variant p.Val60Leu) and enhanced ubiquitination and proteasomal degradation of the protein (variant p.Phe109Ser), demonstrating that different borderline alleles can be destabilized at different steps. Mouse genetics has long shown that the threshold of male sex determination is strain-dependent (a Mus poschiavinus Y chromosome causes sex reversal on the C57BL/6J background but not on others), and human oligogenic/digenic inheritance — additional variants in DSD-related genes modifying a primary lesion — is increasingly documented for 46,XY differences of sex development (DSD), but specific modifiers of the human SRY-dependent threshold have not been identified.

The source preprint (Vaiani et al., bioRxiv 2021, never published in a journal) describes an Argentinian pedigree carrying a novel inherited SRY allele, p.Met64Val, in two 46,XY sisters with primary amenorrhea (failure of menstruation to ever begin) and gonadoblastoma/dysgerminoma (two types of gonadal germ-cell tumor), their unaffected father and brother, and an affected paternal XY grandaunt. Whole-genome analysis found no candidate mutations in other sexual-differentiation genes. In a rodent embryonic-gonadal-ridge-derived cell line (CH34) that models the pre-Sertoli cell, the variant retained intermediate partial activity at both Enh13 and TESCO and in Sox9 transactivation (the preprint's Results reports ca. 60% retained activity for p.Met64Val, while its Discussion states ca. 50% with respect to both Sox9 enhancer occupancy and Sox9 transcriptional activation) — the allele sits at the threshold of function, sufficient in the father, insufficient in the daughters. Biophysically, the variant HMG box showed only modestly weakened affinity (dissociation constant KDK_D 32 nM versus 24 nM for wild type) and native bending of a consensus site, but an accelerated dissociation off-rate (koffk_{off} more than threefold faster), with line broadening in nuclear magnetic resonance (NMR) spectra indicating a 'molten' or conformationally exchanging bound state centered on the major-wing core residues. Met64 lies in the hydrophobic wedge and is exposed on one surface of the protein-DNA complex, so it plausibly participates in both DNA bending and protein-protein contacts. On this basis the source asks why and how occupancy is attenuated, and what genetic context decides the phenotypic outcome. The source also outlines the approaches it regards as suited to these questions: fine mapping of SRY-binding sites within Enh13 and TESCO with functional validation by saturation-mutagenesis-type mutation of the mapped sites; a bias-free, genome-wide comparison of wild-type versus variant SRY chromatin binding by sequencing-based occupancy mapping (ChIP-seq, or its higher-resolution exonuclease-digested variant ChIP-exo) with the two proteins compared at comparable intracellular concentrations; and proteomic analysis of the testis-specific enhanceosome.

Problem Statement

Explain, at molecular resolution and in quantitative terms, how the inherited human SRY allele p.Met64Val — a partial-loss-of-function allele that retains near-native DNA affinity and bending but accelerates protein-DNA dissociation and 'molten'-state conformational dynamics — attenuates occupancy of the endogenous testis-specific Sox9 enhancers Enh13 and TESCO to roughly half of wild type (the preprint's Results reports ca. 60% retained activity for p.Met64Val while its Discussion states ca. 50% with respect to both Sox9 enhancer occupancy and Sox9 transcriptional activation; the quantitative target is this partial-attenuation regime rather than a single fixed number), and why that partial attenuation suffices to tip the bipotential gonad from testis to ovarian differentiation in some carriers but not others. The source summarizes its open question as investigating the structural and biophysical mechanisms leading to attenuated occupancies of SRY-responsive enhancers, and raises the following unresolved questions bearing on that goal: (a) which mechanism accounts for the attenuated occupancy — the source raises, as possibilities that are neither exhaustive nor mutually exclusive, subtle changes in DNA bend angle at non-consensus SRY-binding sites within Enh13 and TESCO, disruption of protein-protein interactions within the SRY-directed enhanceosome, and variant-complex conformational dynamics that either impair enhanceosome assembly or increase susceptibility to proteasomal degradation (the degradation branch imported by analogy from the p.Phe109Ser precedent); a combination of these, or another explanation consistent with the data — including the source's own caveat that it is not clear that the kinetic perturbation is sufficiently marked to affect transcriptional potency — remains open; (b) whether the mutation alters occupancy at sites beyond the known testis-specific enhancers; (c) the protein composition of the testis-specific SRY enhanceosome and which SRY-interacting proteins (if any) engage the exposed Met64 surface; and (d) what sets the molecular threshold of human sex determination and thereby produces the father-daughter paradox in this pedigree — genetic-background modifiers awaiting discovery, digenic regulatory variants or epigenetic events, or stochastic threshold crossing, which the source explicitly offers as an alternative and which is hard to distinguish from oligogenic contributions — together with the resulting genotype-phenotype correlations for inherited SRY mutations. Parts (a) through (d) are linked aspects of this single open question. Clinical long-term follow-up of the probands named by the source (tumor surveillance, refinement of counseling) lies outside the research question posed here.

References

  1. Vaiani E, Chen Y-S, Ramirez P, Racca JD, Baquedano MS, Malosetti C, Touzon MS, Marino R, Costanzo M, Bailez M, Berensztein E, Galluzzo-Mutti ML, Chatterjee D, Yang Y, Belgorosky A, Weiss MA. Genetic, Genomic and Biophysical Case Study: Familial 46, XY Sex Reversal due to a Novel Inherited Mutation in Human Testis-Determining Factor SRY. bioRxiv preprint, posted 2021-05-06 (2021). DOI 10.1101/2021.05.05.442859. https://doi.org/10.1101/2021.05.05.442859 (single preprint version, never journal-published)
  2. Chen Y-S, Racca JD, Weiss MA. Tenuous Transcriptional Threshold of Human Sex Determination. I. SRY and Swyer Syndrome at the Edge of Ambiguity. Frontiers in Endocrinology 13:945030 (2022). DOI 10.3389/fendo.2022.945030. https://doi.org/10.3389/fendo.2022.945030
  3. Racca JD, Chatterjee D, Chen Y-S, Rai RK, Yang Y, Georgiadis MM, Haas E, Weiss MA. Tenuous transcriptional threshold of human sex determination. II. SRY exploits water-mediated clamp at the edge of ambiguity. Frontiers in Endocrinology 13:1029177 (2022). DOI 10.3389/fendo.2022.1029177. https://doi.org/10.3389/fendo.2022.1029177
  4. Racca JD, Chen YS, Brabender AR, Battistin U, Weiss MA, Georgiadis MM. Role of nucleobase-specific interactions in the binding and bending of DNA by human male sex determination factor SRY. Journal of Biological Chemistry 300(9):107683 (2024). DOI 10.1016/j.jbc.2024.107683. https://doi.org/10.1016/j.jbc.2024.107683
  5. Chen Y-S, Thomson E, Pelosi E, Weiss MA. Human Sex Determination: SRY Length Regulates Its Cellular Stability And Hence The Robustness Of Testis Differentiation (ENDO 2024 conference abstract 12554). Journal of the Endocrine Society 8(Suppl_1) (2024). DOI 10.1210/jendso/bvae163.1696. https://doi.org/10.1210/jendso/bvae163.1696
  6. Idris FP, van den Bergen J, Robevska G, Ferreira LGA, Ferreira KR, Kizys MML, Dias da Silva MR, Bruggenwirth HT, van Bever Y, Sinclair AH, Ayers KL. Functional analysis of SRY variants in individuals with 46,XY differences of sex development. Molecular and Cellular Endocrinology 598:112458 (2025). DOI 10.1016/j.mce.2025.112458. https://doi.org/10.1016/j.mce.2025.112458
  7. Bhandari RK, Haque MM, Skinner MK. Global genome analysis of the downstream binding targets of testis determining factor SRY and SOX9. PLoS ONE 7(9):e43380 (2012). DOI 10.1371/journal.pone.0043380. https://doi.org/10.1371/journal.pone.0043380
  8. Ogawa Y, Tsuchiya I, Yanai S, Baba T, Morohashi KI, Sasaki T, Sasaki J, Terao M, Tsuji-Hosokawa A, Takada S. GATA4 binding to the Sox9 enhancer mXYSRa/Enh13 is critical for testis differentiation in mouse. Communications Biology 8:81 (2025). DOI 10.1038/s42003-025-07504-2. https://doi.org/10.1038/s42003-025-07504-2
  9. Stévant I, Abberbock E, Ridnik M, Weiss R, Swisa L, Futtner CR, Maatouk DM, Lovell-Badge R, Malysheva V, Gonen N. The gene regulatory landscape driving mouse gonadal supporting cell differentiation. Science Advances 11(30):eadv1885 (2025). DOI 10.1126/sciadv.adv1885. https://doi.org/10.1126/sciadv.adv1885
  10. Okuyama H, Tokunaga A, Hayashi S, Nakasako K, Tsukamoto D, Matsuo T, Tamura K, Ito M. The Tolerated functional decline Model: Relaxed constraint in the molecular evolution of mammalian master Sex-Determining gene SRY. Gene 973:149844 (2025). DOI 10.1016/j.gene.2025.149844. https://doi.org/10.1016/j.gene.2025.149844
  11. Kouri C, Sommer G, Flück CE. Oligogenic Causes of Human Differences of Sex Development: Facing the Challenge of Genetic Complexity. Hormone Research in Paediatrics 96(2):169-179 (2023). DOI 10.1159/000519691. https://doi.org/10.1159/000519691
  12. Kouri C, Martinez de Lapiscina I, Naamneh-Elzenaty R, Sommer G, Sauter KS, Flück CE; SF1next study group. Oligogenic analysis across broad phenotypes of 46,XY differences in sex development associated with NR5A1/SF-1 variants: findings from the international SF1next study. EBioMedicine 113:105624 (2025). DOI 10.1016/j.ebiom.2025.105624. https://doi.org/10.1016/j.ebiom.2025.105624
  13. McElreavey K, Elzaiat M, Bashamboo A. Digenic, oligogenic and genetic modifiers in disorders/differences of sex development (DSD). Expert Review of Endocrinology and Metabolism 20(5):345-347 (2025). DOI 10.1080/17446651.2025.2529391. https://doi.org/10.1080/17446651.2025.2529391
  14. Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453(7197):930-934 (2008). DOI 10.1038/nature06944. https://doi.org/10.1038/nature06944
  15. Gonen N, Futtner CR, Wood S, Garcia-Moreno SA, Salamone IM, Samson SC, Sekido R, Poulat F, Maatouk DM, Lovell-Badge R. Sex reversal following deletion of a single distal enhancer of Sox9. Science 360(6396):1469-1473 (2018). DOI 10.1126/science.aas9408. https://doi.org/10.1126/science.aas9408
  16. Croft B, Ohnesorg T, Hewitt J, Bowles J, Quinn A, Tan J, Corbin V, Pelosi E, van den Bergen J, Sreenivasan R, Knarston I, Robevska G, Vu DC, Hutson J, Harley V, Ayers K, Koopman P, Sinclair A. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9. Nature Communications 9:5319 (2018). DOI 10.1038/s41467-018-07784-9. https://doi.org/10.1038/s41467-018-07784-9
  17. Racca JD, Chen Y-S, Yang Y, Phillips NB, Weiss MA. Human Sex Determination at the Edge of Ambiguity: inherited XY sex reversal due to enhanced ubiquitination and proteasomal degradation of a master transcription factor. Journal of Biological Chemistry 291(42):22173-22195 (2016). DOI 10.1074/jbc.M116.741959. https://doi.org/10.1074/jbc.M116.741959
  18. Eicher EM, Washburn LL, Whitney JB, Morrow KE. Mus poschiavinus Y Chromosome in the C57BL/6J Murine Genome Causes Sex Reversal. Science 217(4559):535-537 (1982). DOI 10.1126/science.7089579. https://doi.org/10.1126/science.7089579